Endometrial Cancer
GSK’s Jemperli Shows Promise in Endometrial Cancer Trial – FDA Label Expansion on the Horizon
Anika Sharma
GSK has achieved a significant milestone with its PD-1 inhibitor, Jemperli, in the treatment of endometrial cancer, potentially opening the ...
Endometrial Cancer Patients Get New Option with Jemperli
SG Tylor
Source – GSK GSK has secured approval from the US for Jemperli, in combination with chemotherapy, as a first-line treatment ...
Endometrial Cancer: Symptoms, Risks, and Treatments
SG Tylor
Endometrial cancer is the most common type of uterine cancer. Find out what causes it, how to spot the warning ...
